CAREDX, INC. (CDNA) FY2026 Q2 P&L / Income Statement

CAREDX, INC. (CDNA) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories.

Total revenue

131,948,000 US dollars

Cost of revenue (calculated)

34,966,000 US dollars

Gross profit (calculated)

96,982,000 US dollars

Operating expenses (calculated)

negative 16,241,000 US dollars

Income (loss) from operations

113,223,000 US dollars

Total other income

1,295,000 US dollars

Income (loss) before income taxes

114,518,000 US dollars

Income tax (expense) benefit

3,882,000 US dollars

Net income (loss)

110,636,000 US dollars

Testing services revenue revenue

99,927,000 US dollars

Product revenue revenue

12,791,000 US dollars

Patient and digital solutions revenue revenue

19,230,000 US dollars

Testing services revenue cost of revenue

15,918,000 US dollars

Product revenue cost of revenue

4,342,000 US dollars

Patient and digital solutions revenue cost of revenue

14,706,000 US dollars

Research and development

22,376,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Sales and marketing

33,441,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

General and administrative

40,908,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Litigation settlement expense

0 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.